{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:21:35Z","timestamp":1761196895744},"reference-count":25,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T00:00:00Z","timestamp":1219795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J of Urology"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>Objectives:\u2003<\/jats:bold> Pleiotropic effects of recombinant human erythropoietin (EPO) have recently been discovered in many non\u2010renal animal models. The renoprotective effects of EPO and carbamylated\u2010erythropoietin (CEPO), a novel EPO which has a small stimulatory effect on hemoglobin, have never been explored in unilateral ureteral obstruction (UUO), a chronic tubulointerstitial (TI) disease model which is independent of systemic factors.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> In order to examine the effects of EPO and CEPO treatments on renal TI injury, 36 male Sprague\u2010Dawley rats, weighing 250\u2013320\u2003g, underwent: UUO without treatment (group 1, <jats:italic>n<\/jats:italic>\u2003=\u200312), UUO with EPO (groups 2, <jats:italic>n<\/jats:italic>\u2003=\u200312), and UUO with CEPO (group 3, <jats:italic>n<\/jats:italic>\u2003=\u200312). EPO and CEPO were injected subcutaneously at a dose of 5000\u2003u\/kg to each respective rat at 1\u2003day pre\u2010UUO and at day 3, 7 and 10 post\u2010UUO. After days 3, 7, and 14 of UUO, TI injury, collagen, \u03b1\u2010smooth muscle actin (\u03b1\u2010SMA) positive cell, ED1\u2010positive cell, terminal deoxynucleotidyl transferase (TdT) mediated nick\u2010end labeling (TUNEL)\u2010positive cell, and transforming growth factor\u2010\u03b21 (TGF\u2010\u03b21) messenger ribonucleic acid (mRNA) were determined. Bcl\u20102 expression was also assessed to verify the mechanism of apoptosis.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> At day 14 UUO caused severe TI injury with a significant increase in collagen, \u03b1\u2010SMA, ED1\u2010positive cell, TUNEL\u2010positive cell, and TGF\u2010\u03b21 mRNA expression. Administration of EPO and CEPO significantly attenuated TI injury, collagen, ED1\u2010positive cells, and TUNEL\u2010positive cells. Only CEPO\u2010treated rats had decreased \u03b1\u2010SMA positive cells and TGF\u2010\u03b21 mRNA. The expression of Bcl\u20102 was demonstrated only in EPO\u2010treated rats. The hematocrit levels in EPO\u2010treated rats were higher than the control and CEPO\u2010treated rats.<\/jats:p><jats:p><jats:bold>Conclusions:\u2003<\/jats:bold> EPO and CEPO can limit 14\u2010day UUO\u2010induced TI injury by reducing inflammation, interstitial fibrosis, and tubular apoptosis.<\/jats:p>","DOI":"10.1111\/j.1442-2042.2008.02149.x","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T23:55:15Z","timestamp":1219881315000},"page":"1011-1017","source":"Crossref","is-referenced-by-count":18,"title":["Erythropoietin and its non\u2010erythropoietic derivative: Do they ameliorate renal tubulointerstitial injury in ureteral obstruction?"],"prefix":"10.1111","volume":"15","author":[{"given":"Nattachai","family":"Srisawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krissanapong","family":"Manotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somchit","family":"Eiam\u2010Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pisut","family":"Katavetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kearkiat","family":"Praditpornsilpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somchai","family":"Eiam\u2010Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,23]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.9"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.2.524.524"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000135059.67385.5D"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1687"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0098"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00441.2003"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365590310006291"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271434"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00220.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66622-6"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000139335.04152.F3"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00797.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.02.170"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00847.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg547"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1191fje"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2006.06.019"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000084275"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001815"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.12.099"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098313"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00612.x"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.05.207"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.18388\/abp.2005_3440","article-title":"Heme oxygenase\u20101 expression in disease states","volume":"52","author":"Deshane J","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm842"}],"container-title":["International Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-2042.2008.02149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-2042.2008.02149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T19:23:19Z","timestamp":1697397799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-2042.2008.02149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,23]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1442-2042.2008.02149.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02149.x","archive":["Portico"],"relation":{},"ISSN":["0919-8172","1442-2042"],"issn-type":[{"value":"0919-8172","type":"print"},{"value":"1442-2042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,23]]}}}